Although the S1P and STAT3 signaling pathways are mostly reported in cancer research, a recent preclinical study of multiple sclerosis suggests that S1PR1 in microglia promotes the activation of downstream STAT3 signaling pathways in microglia [40, 47, 48]. The gene discussed is STAT3; the disease is cancer.